---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-002678"
form_type: "8-K"
ticker: "ALKS"
cik: "0001520262"
company_name: "Alkermes plc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:14:33.108051+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Alkermes to present at J.P. Morgan Healthcare Conference; highlights profitability and neuroscience focus

## Summary
- Presentation on Jan 10, 2024, titled 'Profitable, Pure-play Neuroscience Company'.
- CEO Richard Pops to present at the 42nd Annual J.P. Morgan Healthcare Conference.
- No specific financial or operational data disclosed in the excerpt provided.

## SEC filing metadata
- accession: 0000950170-24-002678
- form_type: 8-K
- ticker: ALKS
- cik: 0001520262
- company_name: Alkermes plc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1520262/000095017024002678/0000950170-24-002678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1520262/000095017024002678/alks-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-002678
- JSON: https://secwatch.observer/filing/0000950170-24-002678.json
- Plain text: https://secwatch.observer/filing/0000950170-24-002678.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.